Clorox Company has announced a significant leadership change, appointing Fabian Garcia as its new Chief Executive Officer (CEO), effective January 5, 2027. Garcia will succeed Linda Rendle, who will step down from her role as CEO and Chair but will remain with the company as a senior advisor until April 2027. This transition is seen as a pivotal moment for Clorox as it seeks to strengthen its position in the specialty cleaning industry.
Garcia, who is currently the Business Group President for Personal Care at Unilever, brings a wealth of experience in consumer goods to Clorox. His appointment comes after a comprehensive search process, indicating the company's commitment to finding a leader capable of navigating the complexities of the market and driving growth.
Background on Clorox
The Clorox Company, incorporated in Delaware, operates under the SIC code 2842, which pertains to Specialty Cleaning, Polishing and Sanitation Preparations. The company trades on the New York Stock Exchange under the ticker symbol CLX. Clorox has been a prominent player in the consumer goods sector, known for its cleaning products and commitment to sustainability.
What the Filing Says
According to the recent SEC filing, the Board of Directors appointed Garcia on October 28, 2026. The filing states, "Linda Rendle will step down from her role as CEO... and will serve as a senior advisor to the Company through April 2, 2027, to assist with transition matters." Matthew J. Shattock will take over as Independent Chair of the Board, receiving a retainer of $225,000.
Impact
This leadership change may affect various stakeholders, including employees, shareholders, and customers. With Garcia's extensive background in leading large-scale consumer businesses, his leadership is expected to bring a fresh perspective to Clorox's operations and strategic direction. The transition period will allow for continuity as Rendle assists Garcia in acclimating to his new role.
What's Next
The filing does not specify what happens next, but it indicates that further details regarding Garcia's compensation and the advisory arrangement with Rendle will be disclosed in future filings, including the upcoming Quarterly Report on Form 10-Q for the quarter ending December 31, 2026.
Read Next
Community Capital Trust Reports Strong Financials in Filing
Aurora Cannabis to Host Investor Call for Q2 2027 Results
Clorox Appoints Fabian Garcia as New CEO, Effective January 2027
Haleon announces Q3 trading results for 2026
Neo-Concept International Group approves share consolidation
Davis Mark Dean Reports Changes in Stock Ownership










